By ROSSELLA TERCATIN
SEPTEMBER 26, 2021 20:24

After two shots of the coronavirus vaccines, only a minority of renal transplant recipients – some 35% – developed neutralizing antibodies, new research conducted at the Sheba Medical has shown ...

The paper was published in the journal Transplantation, while the physicians are already working on a follow-up study considering the immune response after the booster, with possibly 86% developing antibodies ...

“Renal transplants are a high-risk population for COVID-19 infection and complications, including prolonged hospitalizations and mortality,” she noted. “At the same time, these individuals don’t respond well to vaccines. With the coronavirus epidemic, therefore, it was important for us to explore the response to the vaccine.”

Patients who undergo renal transplants are prescribed immunosuppressive drugs after the surgery for the remainder of their lives, to prevent their immune system from rejecting the organ they received. This same mechanism interferes with the immune system's ability to deal with illness or to create antibodies from vaccinations ...

https://www.jpost.com/health-and-wellness/3rd-covid-vaccine-seems-to-be-gamechanger-for-renal-transplant-recipients-680360